Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach

被引:263
作者
Chi, DS
Franklin, CC
Levine, DA
Akselrod, F
Sabbatini, P
Jarnagin, WR
DeMatteo, R
Poynor, EA
Abu-Rustum, NR
Barakat, RR
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Nassau Cty Med Ctr, Dept Obstet & Gynecol, Long Isl City, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, Dev Chemotherapy Serv, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatobiliary Serv, New York, NY 10021 USA
关键词
fallopian tube; cytoreduction; primary peritoneal cancer;
D O I
10.1016/j.ygyno.2004.01.029
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To determine the impact of the incorporation of extensive upper abdominal debulking procedures on the rates of optimal primary cytoreduction and complications in stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal carcinomas. Methods. Two groups of patients were identified for comparison. Group 1, the control group, consisted of 70 consecutive patients who underwent "standard" primary cytoreductive surgery before May 2000. Group 2, the study group, was composed of 70 consecutive patients who underwent surgery after January 2001, during which time, a more comprehensive debulking of upper abdominal disease was used, including diaphragm stripping/resection, splenectomy, distal pancreatectomy, liver resection, resection of porta hepatis tumor, and cholecystectomy. Results. The median age of the entire cohort was 60 years (range, 36-88 years). The majority had stage IIIC disease (86%) and serous histology (76%). Optimal cytoreduction (residual disease less than or equal to1 cm) rates were 50% for group 1 and 76% for group 2 (P < 0.01). Patients in group 2 were more likely to have undergone extensive procedure(s) (27% versus 3%; P < 0.001). Operative time and estimated blood loss were greater in group 2 than group 1 (264 versus 174 min, 880 versus 460 cc, respectively; P < 0.001 for both). Complication rates and length of hospitalization were not significantly different between the two groups. Conclusion. The use of extensive upper abdominal surgical procedures significantly increased the rate of optimal primary cytoreduction. Although operative time and estimated blood loss were increased, the rate of major complications and length of hospitalization remained the same. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:650 / 654
页数:5
相关论文
共 17 条
[1]  
[Anonymous], GYNECOL ONCOL
[2]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[3]   The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma [J].
Chi, DS ;
Venkatraman, ES ;
Masson, V ;
Hoskins, WJ .
GYNECOLOGIC ONCOLOGY, 2000, 77 (02) :227-231
[4]   Identification of prognostic factors in advanced epithelial ovarian carcinoma [J].
Chi, DS ;
Liao, JB ;
Leon, LF ;
Venkatraman, ES ;
Hensley, ML ;
Bhaskaran, D ;
Hoskins, WJ .
GYNECOLOGIC ONCOLOGY, 2001, 82 (03) :532-537
[5]   Stage IV ovarian cancer: Impact of surgical debulking [J].
Curtin, JP ;
Malik, R ;
Venkatraman, ES ;
Barakat, RR ;
Hoskins, WJ .
GYNECOLOGIC ONCOLOGY, 1997, 64 (01) :9-12
[6]   Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study [J].
Eisenkop, SM ;
Friedman, RL ;
Wang, HJ .
GYNECOLOGIC ONCOLOGY, 1998, 69 (02) :103-108
[7]   Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study [J].
Eisenkop, SM ;
Spirtos, NM ;
Friedman, RL ;
Lin, WCM ;
Pisani, AL ;
Perticucci, S .
GYNECOLOGIC ONCOLOGY, 2003, 90 (02) :390-396
[8]   What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? [J].
Eisenkop, SM ;
Spirtos, NM .
GYNECOLOGIC ONCOLOGY, 2001, 82 (03) :489-497
[9]  
Griffiths C T, 1975, Natl Cancer Inst Monogr, V42, P101
[10]   THE EFFECT OF DIAMETER OF LARGEST RESIDUAL DISEASE ON SURVIVAL AFTER PRIMARY CYTOREDUCTIVE SURGERY IN PATIENTS WITH SUBOPTIMAL RESIDUAL EPITHELIAL OVARIAN-CARCINOMA [J].
HOSKINS, WJ ;
MCGUIRE, WP ;
BRADY, MF ;
HOMESLEY, HD ;
CREASMAN, WT ;
BERMAN, M ;
BALL, H ;
BEREK, JS .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (04) :974-980